Authors: STUBBS P SEED M LANE D COLLINSON P KENDALL F NOBLE M

Citation: P. Stubbs et al., LIPOPROTEIN(A) AS A RISK PREDICTOR FOR CARDIAC MORTALITY IN PATIENTS WITH ACUTE CORONARY SYNDROMES, European heart journal, 19(9), 1998, pp. 1355-1364

Authors: STUBBS P COLLINSON P KENDALL F NOBIE M SEED M

Citation: P. Stubbs et al., THE PROGNOSTIC-SIGNIFICANCE OF LIPOPROTEIN(A) CONCENTRATIONS FOLLOWING MYOCARDIAL-INFARCTION, HEART, 75(5), 1996, pp. 249-249

Authors: ATKIN KJ KENDALL F ARELLANO F OSULLIVAN DP KRUPP P

Citation: Kj. Atkin et al., CLOZARIL (CLOZAPINE) ASSOCIATED NEUTROPENIA AND AGRANULOCYTOSIS, Schizophrenia research, 18(2-3), 1996, pp. 1-1

Authors: ATKIN K KENDALL F GOULD D FREEMAN H LIEBERMAN J OSULLIVAN D

Citation: K. Atkin et al., NEUTROPENIA AND AGRANULOCYTOSIS IN PATIENTS RECEIVING CLOZAPINE IN THE UK AND IRELAND, British Journal of Psychiatry, 169(4), 1996, pp. 483-488

Authors: BARNES MP BATES D CORSTON RN CROWDER D DICK DJ EMRE M FINDLEY LJ WOOD H HAWKES CH HAWKINS SA HUDGSON P KENDALL F JEWITT K MOFFAT B MILLAC P PARK D PERKIN GD ROBERTS R SAGAR H SPOKES E

Citation: Mp. Barnes et al., A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF TIZANIDINE IN THE TREATMENT OF SPASTICITY CAUSED BY MULTIPLE-SCLEROSIS, Neurology, 44(11), 1994, pp. 70-78

Authors: LONG CC HILL SA THOMAS RC JOHNSTON A SMITH SG KENDALL F FINLAY AY

Citation: Cc. Long et al., EFFECT OF TERBINAFINE ON THE PHARMACOKINETICS OF CYCLOSPORINE IN HUMANS, Journal of investigative dermatology, 102(5), 1994, pp. 740-743